<DOC>
	<DOCNO>NCT00352261</DOCNO>
	<brief_summary>The purpose study compare treatment esomeprazole 40 mg daily lansoprazole 30 mg daily control intragastric pH Barrett 's Esophagus patient</brief_summary>
	<brief_title>An Open Label pH Comparison Esomeprazole Lansoprazole Barrett 's Esophagus Patients</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Documented history ( within 2 yr histologically proven BE ; Aged 1870 ( inclusive ) ; Willing able comply study procedure Signs clinically significant GI bleeding within 3 day prior randomization ; History gastric esophageal surgery ; Clinically significant illness within 2 week prior first dose study drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Barrett 's Esophagus</keyword>
</DOC>